Skip to main content
. 2016 Sep 17;7(45):74247–74258. doi: 10.18632/oncotarget.12093

Figure 7. p38 participates in LPS improved hierarchical neutrophil chemotaxis.

Figure 7

The results of the under agarose chemotaxis assay showed that fMLP 0.01 μmol/L treatment slightly but not significantly decreased C5a-, IL-8- and LTB4-induced neutrophil chemotaxis. LPS 0.01 μg/mL significantly enhanced the inhibitory effect of fMLP, which was then reverted by the p38 inhibitor but not the MK2 inhibitor. The data are expressed as the mean ± SD, n=5 for each group. *P < 0.05 compared to the control group, #P < 0.05 compared with the fMLP+LPS group.